Ann L. MacDougall - Jun 15, 2021 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role: Director
Signature: /s/ Ann L. MacDougall
Stock symbol: OPNT
Transactions as of: Jun 15, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/16/2021, 04:06 PM
Previous filing: May 13, 2021
Next filing: May 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OPNT	Common Stock	Award	$0	+2K	+9.44%	$0.00	23.2K	Jun 15, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OPNT	Stock Option (right to buy)	Award	$0	+2.5K		$0.00	2.5K	Jun 15, 2021	Common Stock	2.5K	$13.30	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	2,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date.
F2	On June 15, 2021, the reporting person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date.